Biophysical reprogramming of immunosuppressive neutrophils by cold atmospheric plasma reinvigorates antitumor immunity
Cold plasma reprograms immune-suppressing cells in tumors to fight cancer, offering a completely new physics-based approach to boost immunotherapy.
Cold atmospheric plasma (CAP) was shown to convert immunosuppressive tumor-associated neutrophils into pro-inflammatory antitumor effectors through biophysical reprogramming, leading to reinvigorated antitumor immunity. This entirely novel approach—using plasma physics to reshape the tumor immune microenvironment via neutrophil reprogramming—could complement checkpoint immunotherapy.
What the study was
- Study design
- preclinical_in_vivo
- Category
- novel_therapeutics_immunotherapy_cart_targeted
- Maturity
- Exploratory
- Journal
- Science Advances
Why it surfaced
Science Advances publication with entirely novel mechanism (cold plasma neutrophil reprogramming) for circumventing tumor immunosuppression. High novelty score. T6 core hit.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.